Surgical Innovations appoints new President of US Sales and Operations

Surgical Innovations Group, the AIM-listed manufacturer of creative solutions for minimally invasive surgery, has appointed Rick Barnett as President of US Sales and Operations with immediate effect.

The company reported that Barnett had joined the company from Integrated Medical Systems, where he worked in the Management and Consulting Division. Within this role, Barnett managed a division that provided on-site clinical support for minimally invasive procedures.

An important focus for Surgical Innovations' strategy moving forward was to drive the Surgical Innovations' branded products through investment in sales and marketing especially in the US, the company said.

Start your trial of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

Sign up for MoneyWeek’s free twice-daily newsletter.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.

Sign up

Barnett will have responsibility for managing the several US sales channels Surgical Innovations has previously established and will aim to grow the US business utilising his experience in the endoscopic sector, the company added.

Graham Bowland, Chief Executive Officer of Surgical Innovations, said: "Rick Barnett is an outstanding appointment for Surgical Innovations as we continue to develop our presence in the US market. He brings with him extensive knowledge of the endoscopic industry and a proven track record in developing new business and sales opportunities that will enable him to accelerate the growth of the Surgical Innovations business in the United States."

Surgical Innovations' share price was unchanged at 5.35p at 14:04 on Wednesday.

MF